Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-20
2011-11-01
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08048871
ABSTRACT:
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.
REFERENCES:
patent: WO 2005/087728 (2005-09-01), None
Dorwald, F. ‘Side Reactions in Organic Synthesis, A Guide to Successful Synthesis Design’ Wiley-VCH, Preface, p. ix, 2005.
Jordan, V. ‘Tamoxifen: a most unlikely pioneering medicine’ Nature Reviews, vol. 2, p. 205-213, 2003.
Cannon, J.G. ‘Analog Design’ Burger's Medicinal Chemistry and Drug Discovery, Edition 5, vol. 1, Chapter 19, p. 783-802, 1995.
Horig et al ‘From bench to clinic and back: perspective on the 1stIQPC translation research conference’ Journal of Translational Medicine, 2(44), p. 1-8, 2004.
Schafer et al ‘Failure is an option: learning from unsuccessful proof-of-concept trials’ Drug Discovery Today, 13(21/22), p. 913-916, 2008.
Duan Dehui
Eissenstat Michael
Fetterolf Brandon
Perkins Coie LLP
Sequoia Pharmaceuticals, Inc.
Stone Christopher R
LandOfFree
Compositions and methods for inhibiting cytochrome P450 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibiting cytochrome P450, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting cytochrome P450 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4270227